CCCC fundamentals
C4 Therapeutics, Inc. revenue breakdown overview
C4 Therapeutics, Inc. revenue for the last year amounted to 35.58 M USD, the most of which — 35.58 M USD — came from its highest performing source at the moment, Targeted Protein Degradation, the year earlier bringing 20.76 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought C4 Therapeutics, Inc. 35.58 M USD, and the year before that — 20.76 M USD.
By source
2018
2019
2020
2021
2022
2023
2024
0.00
12.00 M
24.00 M
36.00 M
48.00 M
Targeted Protein Degradation
Currency: USD
2018
2019
2020
2021
2022
2023
2024
Targeted Protein Degradation
33.20 M
45.78 M
31.10 M
20.76 M
35.58 M
By country
2018
2019
2020
2021
2022
2023
2024
0.00
12.00 M
24.00 M
36.00 M
48.00 M
United States
Currency: USD
2018
2019
2020
2021
2022
2023
2024
United States
33.20 M
45.78 M
31.10 M
20.76 M
35.58 M